Although the pandemic of SARS-CoV-2 (COVID-19) has been relatively benign in children compared to adults, there is growing concern about an emerging syndrome that causes severe, sometimes fatal, outcomes in pediatric patients.
Although the pandemic of SARS-CoV-2 (COVID-19) has been relatively benign in children compared to adults, there is growing concern about an emerging syndrome that causes severe, sometimes fatal outcomes in pediatric patients.
In a series of studies in gnotobiotic animals and malnourished children, incomplete recovery from malnutrition is associated with immature gut microbiota, and complementary foods directed to enhance microbiotal maturity improved recovery from malnutrition.
There are some signs of progress in drug-resistant infections in pediatrics, suggesting that antibiotic stewardship efforts may be having an effect and fewer broad-spectrum agents are being used on this important patient group, the Centers for Disease Control and Prevention reports.
Data analysis from The Environmental Determinants of Diabetes in the Young (TEDDY) study, to evaluate risk of celiac autoimmunity and celiac disease in children who screened positive for at-risk human leukocyte antigen genotypes, demonstrated increased risk for both outcomes in genetically predisposed children correlating with increasing quantities of daily gluten intake during the first five years of life.
The 2019-2020 flu season is already among us, and it is imperative that those healthcare practitioners on the frontline, particularly in our nation’s emergency departments, have current knowledge of prevention and treatment strategies.